Update on corpus cavernosum smooth muscle contractile pathways in erectile function: A role for testosterone?

Journal of Sexual Medicine

Volumn 8, Issue 7, 2011, Pages 1865-1879

  Zhang, Xin Hua ^a,b   Melman, Arnold ^a   Disanto, Michael E ^a  

^a UMDNJ Robert Wood Johnson Medical School at Camden   (United States)

^b GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Erectile function; Hypogonadism; Peripheral effects of testosterone on penile smooth muscle; Smooth muscle contraction; Testosterone

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BLEBBISTATIN; ENDOTHELIN 1; ESTRADIOL VALERATE; MYOSIN; MYOSIN HEAVY CHAIN; MYOSIN LIGHT CHAIN; OXYTOCIN; OXYTOCIN RECEPTOR; PHENTOLAMINE; PHENYLEPHRINE; PRAZOSIN; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SILDENAFIL; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; TADALAFIL; TESTOSTERONE; TESTOSTERONE ENANTATE; TESTOSTERONE PROPIONATE; TRIPTORELIN; VARDENAFIL; YOHIMBINE;

ADRENERGIC SYSTEM; ARTICLE; CASTRATION; CLINICAL TRIAL (TOPIC); CONCENTRATION RESPONSE; CORPUS CAVERNOSUM; CORPUS CAVERNOSUM SMOOTH MUSCLE; DIABETES MELLITUS; DOWN REGULATION; DRUG EFFICACY; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG SYNTHESIS; DRUG TARGETING; ELECTROSTIMULATION; ENDOTHELIAL DYSFUNCTION; ERECTILE DYSFUNCTION; ERECTILE FUNCTION; EXTRACELLULAR MATRIX; HUMAN; HYPOGONADISM; HYPOGONADOTROPIC HYPOGONADISM; MEAN ARTERIAL PRESSURE; NERVE STIMULATION; NONHUMAN; PEER REVIEW; PENIS ERECTION; PRIAPISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; SEXUAL FUNCTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTILITY; TESTOSTERONE BLOOD LEVEL; TREATMENT RESPONSE; TUNICA ALBUGINEA; UPREGULATION;

EID: 79959191951     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2011.02218.x     Document Type: Article

References (136)

1. Andersson KE. Pharmacology of penile erection. Pharmacol Rev 2001;53:417-50.
2. DiSanto ME. Corpus cavernosum smooth muscle physiology: A role for sex hormones? J Androl 2003;24:S6-16.
3. Morelli A, Filippi S, Zhang XH, Luconi M, Vignozzi L, Mancina R, Maggi M. Peripheral regulatory mechanisms in erection. Int J Androl 2005;28(2 suppl):23-7.
4. Buvat J, Maggi M, Gooren L, Guay AT, Kaufman J, Morgentaler A, Schulman C, Tan HM, Torres LO, Yassin A, Zitzmann M. Endocrine aspects of male sexual dysfunctions. J Sex Med 2010;7:1627-56.
5. Palese MA, Crone JK, Burnett AL. A castrated mouse model of erectile dysfunction. J Androl 2003;24:699-703.
6. Baba K, Yajima M, Carrier S, Morgan DM, Nunes L, Lue TF, Iwamoto T. Delayed testosterone replacement restores nitric oxide synthase-containing nerve fibres and the erectile response in rat penis. BJU Int 2000;85:953-8.
7. Mills TM, Stopper VS, Wiedmeier VT. Effects of castration and androgen replacement on the hemodynamics of penile erection in the rat. Biol Reprod 1994;51:234-8.
8. Reilly CM, Stopper VS, Mills TM. Androgens modulate the alpha-adrenergic responsiveness of vascular smooth muscle in the corpus cavernosum. J Androl 1997;18:26-31.
9. Traish AM, Munarriz R, O'Connell L, Choi S, Kim SW, Kim NN, Huang YH, Goldstein I. Effects of medical or surgical castration on erectile function in an animal model. J Androl 2003;24:381-7.
10. Wingard CJ, Johnson JA, Holmes A, Prikosh A. Improved erectile function after Rho-kinase inhibition in a rat castrate model of erectile dysfunction. Am J Physiol Regul Integr Comp Physiol 2003;284:R1572-9.
11. Zhang XH, Morelli A, Luconi M, Vignozzi L, Filippi S, Marini M, Vannelli GB, Mancina R, Forti G, Maggi M. Testosterone regulates PDE5 expression and in vivo responsiveness to tadalafil in rat corpus cavernosum. Eur Urol 2005;47:409-16.
12. Choi SK, Han SW, Kim DH, de Lignieres LB. Transdermal dihydrotestosterone therapy and its effects on patients with microphallus. J Urol 1993;150:657-60.
13. Ben-Galim E, Hillman RE, Weldon VV. Topically applied testosterone and phallic growth. Its effects in male children with hypopituitarism and microphallus. Am J Dis Child 1980;134:296-8.
14. Bancroft J, Wu FC. Changes in erectile responsiveness during androgen replacement therapy. Arch Sex Behav 1983;12:59-66.
15. Kinsey A, Pomeroy W, Martin C. Sexual behaviour in the human male. Philadelphia: W.B. Saunders; 1948:218-62.
16. Kwan M, Greenleaf WJ, Mann J, Crapo L, Davidson JM. The nature of androgen action on male sexuality: A combined laboratory-self-report study on hypogonadal men. J Clin Endocrinol Metab 1983;57:557-62.
17. Shirozu H, Koyanagi T, Takashima T, Horimoto N, Akazawa K, Nakano H. Penile tumescence in the human fetus at term-A preliminary report. Early Hum Dev 1995;41:159-66.
18. Weinberger LE, Sreenivasan S, Garrick T, Osran H. The impact of surgical castration on sexual recidivism risk among sexually violent predatory offenders. J Am Acad Psychiatry Law 2005;33:16-36.
19. McGill TE, Manning A. Genotype and retention of the ejaculatory reflex in castrated male mice. Anim Behav 1976;24:507-18.
20. Clemens LG, Wee BE, Weaver DR, Roy EJ, Goldman BD, Rakerd B. Retention of masculine sexual behavior following castration in male B6D2F1 mice. Physiol Behav 1988;42:69-76.
21. Filippi S, Morelli A, Sandner P, Fibbi B, Mancina R, Marini M, Gacci M, Vignozzi L, Vannelli GB, Carini M, Forti G, Maggi M. Characterization and functional role of androgen-dependent PDE5 activity in the bladder. Endocrinology 2007;148:1019-29.
22. Morelli A, Filippi S, Mancina R, Luconi M, Vignozzi L, Marini M, Orlando C, Vannelli GB, Aversa A, Natali A, Forti G, Giorgi M, Jannini EA, Ledda F, Maggi M. Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa. Endocrinology 2004;145:2253-63.
23. Zhang XH, Filippi S, Morelli A, Vignozzi L, Luconi M, Donati S, Forti G, Maggi M. Testosterone restores diabetes-induced erectile dysfunction and sildenafil responsiveness in two distinct animal models of chemical diabetes. J Sex Med 2006;3:253-64.
24. Traish AM, Park K, Dhir V, Kim NN, Moreland RB, Goldstein I. Effects of castration and androgen replacement on erectile function in a rabbit model. Endocrinology 1999;140:1861-8.
25. Traish AM, Guay AT. Are androgens critical for penile erections in humans? Examining the clinical and preclinical evidence. J Sex Med 2006;3:382-404.
26. Filippi S, Vignozzi L, Morelli A, Chavalmane AK, Sarchielli E, Fibbi B, Saad F, Sandner P, Ruggiano P, Vannelli GB, Mannucci E, Maggi M. Testosterone partially ameliorates metabolic profile and erectile responsiveness to PDE5 inhibitors in an animal model of male metabolic syndrome. J Sex Med 2009;6:3274-88.
27. Vignozzi L, Filippi S, Morelli A, Marini M, Chavalmane A, Fibbi B, Silvestrini E, Mancina R, Carini M, Vannelli GB, Forti G, Maggi M. Cavernous neurotomy in the rat is associated with the onset of an overt condition of hypogonadism. J Sex Med 2009;6:1270-83.
28. Baba K, Yajima M, Carrier S, Akkus E, Reman J, Nunes L, Lue TF, Iwamoto T. Effect of testosterone on the number of NADPH diaphorase-stained nerve fibers in the rat corpus cavernosum and dorsal nerve. Urology 2000;56:533-8.
29. Chamness SL, Ricker DD, Crone JK, Dembeck CL, Maguire MP, Burnett AL, Chang TS. The effect of androgen on nitric oxide synthase in the male reproductive tract of the rat. Fertil Steril 1995;63:1101-7.
30. Lugg JA, Rajfer J, Gonzalez-Cadavid NF. Dihydrotestosterone is the active androgen in the maintenance of nitric oxide-mediated penile erection in the rat. Endocrinology 1995;136:1495-501.
31. Park KH, Kim SW, Kim KD, Paick JS. Effects of androgens on the expression of nitric oxide synthase mRNAs in rat corpus cavernosum. BJU Int 1999;83:327-33.
32. Penson DF, Ng C, Cai L, Rajfer J, Gonzalez-Cadavid NF. Androgen and pituitary control of penile nitric oxide synthase and erectile function in the rat. Biol Reprod 1996;55:567-74.
33. Reilly CM, Zamorano P, Stopper VS, Mills TM. Androgenic regulation of NO availability in rat penile erection. J Androl 1997;18:110-5.
34. Reilly CM, Lewis RW, Stopper VS, Mills TM. Androgenic maintenance of the rat erectile response via a non-nitric-oxide-dependent pathway. J Androl 1997;18:588-94.
35. Schirar A, Bonnefond C, Meusnier C, Devinoy E. Androgens modulate nitric oxide synthase messenger ribonucleic acid expression in neurons of the major pelvic ganglion in the rat. Endocrinology 1997;138:3093-102.
36. Zvara P, Sioufi R, Schipper HM, Begin LR, Brock GB. Nitric oxide mediated erectile activity is a testosterone dependent event: A rat erection model. Int J Impot Res 1995;7:209-19.
37. Greco EA, Spera G, Aversa A. Combining testosterone and PDE5 inhibitors in erectile dysfunction: Basic rationale and clinical evidences. Eur Urol 2006;50:940-7.
38. Shabsigh R, Kaufman JM, Steidle C, Padma-Nathan H. Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol 2004;172:658-63.
39. Shabsigh R. The effects of testosterone on the cavernous tissue and erectile function. World J Urol 1997;15:21-6.
40. Shen ZJ, Zhou XL, Lu YL, Chen ZD. Effect of androgen deprivation on penile ultrastructure. Asian J Androl 2003;5:33-6.
41. Traish AM, Toselli P, Jeong SJ, Kim NN. Adipocyte accumulation in penile corpus cavernosum of the orchiectomized rabbit: A potential mechanism for veno-occlusive dysfunction in androgen deficiency. J Androl 2005;26:242-8.
42. Zhang XH, Hu LQ, Zheng XM, Li SW. Apoptosis in rat erectile tissue induced by castration. Asian J Androl 1999;1:181-5.
43. Alcorn JF, Toepfer JR, Leipheimer RE. The effects of castration on relaxation of rat corpus cavernosum smooth muscle in vitro. J Urol 1999;161:686-9.
44. Dai YT, Stopper V, Lewis R, Mills T. Effects of castration and testosterone replacement on veno-occlusion during penile erection in the rat. Asian J Androl 1999;1:53-9.
45. Mills TM, Lewis RW, Stopper VS. Androgenic maintenance of inflow and veno-occlusion during erection in the rat. Biol Reprod 1998;59:1413-8.
46. Christ GJ, Maayani S, Valcic M, Melman A. Pharmacological studies of human erectile tissue: Characteristics of spontaneous contractions and alterations in alpha-adrenoceptor responsiveness with age and disease in isolated tissues. Br J Pharmacol 1990;101:375-81.
47. Levin RM, Wein AJ. Adrenergic alpha receptors outnumber beta receptors in human penile corpus cavernosum. Invest Urol 1980;18:225-6.
48. Diederichs W, Lue TF. Reduction of sympathetic influences on penile erection by phentolamine. Urol Int 1991;46:64-6.
49. Muller SC, Hsieh JT, Lue TF, Tanagho EA. Castration and erection. An animal study. Eur Urol 1988;15:118-24.
50. Christ GJ, Lerner SE, Kim DC, Melman A. Endothelin-1 as a putative modulator of erectile dysfunction: I. Characteristics of contraction of isolated corporal tissue strips. J Urol 1995;153:1998-2003.
51. Nakamuta M, Takayanagi R, Sakai Y, Sakamoto S, Hagiwara H, Mizuno T, Saito Y, Hirose S, Yamamoto M, Nawata H. Cloning and sequence analysis of a cDNA encoding human non-selective type of endothelin receptor. Biochem Biophys Res Commun 1991;177:34-9.
52. Sakamoto A, Yanagisawa M, Sakurai T, Takuwa Y, Yanagisawa H, Masaki T. Cloning and functional expression of human cDNA for the ETB endothelin receptor. Biochem Biophys Res Commun 1991;178:656-63.
53. Bell CR, Sullivan ME, Dashwood MR, Muddle JR, Morgan RJ. The density and distribution of endothelin 1 and endothelin receptor subtypes in normal and diabetic rat corpus cavernosum. Br J Urol 1995;76:203-7.
54. Filippi S, Marini M, Vannelli GB, Crescioli C, Granchi S, Vignozzi L, Luconi M, Ferruzzi P, Morelli A, Forti G, Ledda F, Maggi M. Effects of hypoxia on endothelin-1 sensitivity in the corpus cavernosum. Mol Hum Reprod 2003;9:765-74.
55. Chang S, Hypolite JA, Changolkar A, Wein AJ, Chacko S, DiSanto ME. Increased contractility of diabetic rabbit corpora smooth muscle in response to endothelin is mediated via Rho-kinase beta. Int J Impot Res 2003;15:53-62.
56. Takahashi W, Afiatpour P, Foster HE, Ikeda K, Wada Y, Weiss RM, Latifpour J. The effect of castration on endothelins, their receptors and endothelin converting enzyme in rat prostate. Naunyn Schmiedebergs Arch Pharmacol 2002;366:166-76.
57. Padley RJ, Dixon DB, Wu-Wong JR. Effect of castration on endothelin receptors. Clin Sci 2002;103(48 suppl):442S-5S.
58. Filippi S, Luconi M, Granchi S, Natali A, Tozzi P, Forti G, Ledda F, Maggi M. Endothelium-dependency of yohimbine-induced corpus cavernosum relaxation. Int J Impot Res 2002;14:295-307.
59. Saito M, Nishi K, Foster HE Jr, Weiss RM, Latifpour J. Effect of experimental diabetes on rat prostate endothelin receptors. Eur J Pharmacol 1996;310:197-200.
60. Adelstein RS, Eisenberg E. Regulation and kinetics of the actin-myosin-ATP interaction. [Review]. Annu Rev Biochem 1980;49:921-56.
61. Gu H, Martin H, Barsotti RJ, Labelle EF. Rapid increase in inositol phosphate levels in norepinephrine-stimulated vascular smooth muscle. Am J Physiol Cell Physiol 1991;261:C17-22.
62. DiSanto ME, Wang Z, Menon C, Zheng Y, Chacko T, Hypolite J, Broderick G, Wein AJ, Chacko S. Expression of myosin isoforms in smooth muscle cells in the corpus cavernosum penis. Am J Physiol 1998;275:C976-87.
63. Sward K, Mita M, Wilson DP, Deng JT, Susnjar M, Walsh MP. The role of RhoA and Rho-associated kinase in vascular smooth muscle contraction. Curr Hypertens Rep 2003;5:66-72.
64. Ghalayini IF. Nitric oxide-cyclic GMP pathway with some emphasis on cavernosal contractility. Int J Impot Res 2004;16:459-69.
65. Babij P, Kelly C, Periasamy M. Characterization of a mammalian smooth muscle myosin heavy-chain gene: Complete nucleotide and protein coding sequence and analysis of the 5′ end of the gene. Proc Natl Acad. Sci U S A 1991;88:10676-80.
66. 2-terminal-inserted myosin II heavy chain is expressed in smooth muscle of small muscular arteries. Am J Physiol 1997;272:C1532-42.
67. Kelley CA, Takahashi M, Yu JH, Adelstein RS. An insert of seven amino acids confers functional differences between smooth muscle myosins from the intestines and vasculature. J Biol Chem 1993;268:12848-54.
68. Hypolite JA, DiSanto ME, Zheng Y, Chang S, Wein AJ, Chacko S. Regional variation in myosin isoforms and phosphorylation at the resting tone in urinary bladder smooth muscle. Am J Physiol Cell Physiol 2001;280:C254-64.
69. Helper DJ, Lash JA, Hathaway DR. Distribution of isoelectric variants of the 17, 000-dalton myosin light chain in mammalian smooth muscle. J Biol Chem 1988;263:15748-53.
70. Malmqvist U, Arner A. Correlation between isoform composition of the 17 kDa myosin light chain and maximal shortening velocity in smooth muscle. Pflugers Arch 1991;418:523-30.
71. Straight AF, Cheung A, Limouze J, Chen I, Westwood NJ, Sellers JR, Mitchison TJ. Dissecting temporal and spatial control of cytokinesis with a myosin II inhibitor. Science 2003;299:1743-7.
72. Eddinger TJ, Meer DP, Miner AS, Meehl J, Rovner AS, Ratz PH. Potent inhibition of arterial smooth muscle tonic contractions by the selective myosin II inhibitor, blebbistatin. J Pharmacol Exp Ther 2007;320:865-70.
73. Zhang XH, Aydin M, Kuppam D, Melman A, DiSanto ME. In vitro and in vivo relaxation of corpus cavernosum smooth muscle by the selective myosin II inhibitor, blebbistatin. J Sex Med 2009;6:2661-71.
74. Niu Y, Xu Y, Zhang J, Bai J, Yang H, Ma T. Proliferation and differentiation of prostatic stromal cells. BJU Int 2001;87:386-93.
75. Matsui T, Amano M, Yamamoto T, Chihara K, Nakafuku M, Ito M, Nakano T, Okawa K, Iwamatsu A, Kaibuchi K. Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho. EMBO J 1996;15:2208-16.
76. Amano M, Ito M, Kimura K, Fukata Y, Chihara K, Nakano T, Matsuura Y, Kaibuchi K. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem 1996;271:20246-9.
77. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, Yamamori B, Feng J, Nakano T, Okawa K, Iwamatsu A, Kaibuchi K. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). [see comments]. Science 1996;273:245-8.
78. Nakagawa O, Fujisawa K, Ishizaki T, Saito Y, Nakao K, Narumiya S. ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice. FEBS Lett 1996;392:189-93.
79. Wang H, Eto M, Steers WD, Somlyo AP, Somlyo AV. RhoA-mediated Ca2+ sensitization in erectile function. J Biol Chem 2002;277:30614-21.
80. Chang S, Hypolite JA, Zderic SA, Wein AJ, Chacko S, Disanto ME. Increased corpus cavernosum smooth muscle tone associated with partial bladder outlet obstruction is mediated via Rho-kinase. Am J Physiol Regul Integr Comp Physiol 2005;289:R1124-30.
81. Chitaley K, Wingard CJ, Clinton WR, Branam H, Stopper VS, Lewis RW, Mills TM. Antagonism of Rho-kinase stimulates rat penile erection via a nitric oxide-independent pathway. Nat Med 2001;7:119-22.
82. Vignozzi L, Morelli A, Filippi S, Ambrosini S, Mancina R, Luconi M, Mungai S, Vannelli GB, Zhang XH, Forti G, Maggi M. Testosterone regulates RhoA/Rho-kinase signaling in two distinct animal models of chemical diabetes. J Sex Med 2007;4:620-30.
83. Chun J, Goetzl EJ, Hla T, Igarashi Y, Lynch KR, Moolenaar W, Pyne S, Tigyi G. International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature. Pharmacol Rev 2002;54:265-9.
84. Ishii I, Ye X, Friedman B, Kawamura S, Contos JJ, Kingsbury MA, Yang AH, Zhang G, Brown JH, Chun J. Marked perinatal lethality and cellular signaling deficits in mice null for the two sphingosine 1-phosphate (S1P) receptors, S1P(2)/LP(B2)/EDG-5 and S1P(3)/LP(B3)/EDG-3. J Biol Chem 2002;277:25152-9.
85. Lockman K, Hinson JS, Medlin MD, Morris D, Taylor JM, Mack CP. Sphingosine 1-phosphate stimulates smooth muscle cell differentiation and proliferation by activating separate serum response factor co-factors. J Biol Chem 2004;279:42422-30.
86. Zhang G, Contos JJA, Weiner JA, Fukushima N, Chun J. Comparative analysis of three murine G-protein coupled receptors activated by sphingosine-1-phosphate. Gene 1999;227:89-99.
87. Hemmings DG, Xu Y, Davidge ST. Sphingosine 1-phosphate-induced vasoconstriction is elevated in mesenteric resistance arteries from aged female rats. Br J Pharmacol 2004;143:276-84.
88. Graler MH, Bernhardt G, Lipp M. EDG6, a novel G-protein-coupled receptor related to receptors for bioactive lysophospholipids, is specifically expressed in lymphoid tissue. Genomics 1998;53:164-9.
89. Im DS, Heise CE, Ancellin N, O'Dowd BF, Shei GJ, Heavens RP, Rigby MR, Hla T, Mandala S, McAllister G, George SR, Lynch KR. Characterization of a novel sphingosine 1-phosphate receptor, Edg-8. J Biol Chem 2000;275:14281-6.
90. Coussin F, Scott RH, Wise A, Nixon GF. Comparison of sphingosine 1-phosphate-induced intracellular signaling pathways in vascular smooth muscles: Differential role in vasoconstriction. Circ Res 2002;91:151-7.
91. Waeber C, Blondeau N, Salomone S. Vascular sphingosine-1-phosphate S1P1 and S1P3 receptors. Drug News Perspect 2004;17:365-82.
92. Okamoto H, Takuwa N, Yokomizo T, Sugimoto N, Sakurada S, Shigematsu H, Takuwa Y. Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3. Mol Cell Biol 2000;20:9247-61.
93. di Villa BR, Sorrentino R, Sorrentino R, Imbimbo C, Palmieri A, Fusco F, Maggi M, De Palma R, Cirino G, Mirone V. Sphingosine 1-phosphate induces endothelial nitric-oxide synthase activation through phosphorylation in human corpus cavernosum. J Pharmacol Exp Ther 2006;316:703-8.
94. Sandhu KS, Chua RG, Zhang X, Kanika ND, Collins SA, Mikhail M, Melman A, DiSanto ME. Regional heterogeneity in expression of the sphingosine-1-phosphate pathway in the female rat lower urinary tract. Am J Obstet Gynecol 2009;200:576-7.
95. Ohmori T, Yatomi Y, Osada M, Kazama F, Takafuta T, Ikeda H, Ozaki Y. Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P2. Cardiovasc Res 2003;58:170-7.
96. Salomone S, Yoshimura S, Reuter U, Foley M, Thomas SS, Moskowitz MA, Waeber C. S1P3 receptors mediate the potent constriction of cerebral arteries by sphingosine-1-phosphate. Eur J Pharmacol 2003;469:125-34.
97. Hu W, Mahavadi S, Huang J, Li F, Murthy KS. Characterization of S1P1 and S1P2 receptor function in smooth muscle by receptor silencing and receptor protection. Am J Physiol Gastrointest Liver Physiol 2006;291:G605-10.
98. Zhou H, Murthy KS. Distinctive G protein-dependent signaling in smooth muscle by sphingosine 1-phosphate receptors S1P1 and S1P2. Am J Physiol Cell Physiol 2004;286:C1130-8.
99. Igarashi J, Erwin PA, Dantas AP, Chen H, Michel T. VEGF induces S1P1 receptors in endothelial cells: Implications for cross-talk between sphingolipid and growth factor receptors. Proc Natl Acad Sci U S A 2003;100:10664-9.
100. DiSanto M, Chua R, Tar M, Kanika N, Kuppam D, Melmon A. Sphingosine-1-phosphate (S1P) signaling pathway in diabetes-induced erectile dysfunction (ED): Potential for s1p as a biomarker of diabetes-induced ED. J Urol 2008;179(1 suppl):336.
101. Zhang X, Adin M, Melman A, DiSanto M. Sphingosine-1-phospate induced contraction of human corpus cavernosum smooth muscle is mediated by the rho-kinase pathway and is upregulated by diabetes. J Sex Med 2009;6(1 suppl):7.
102. Aydin M, Downing K, Villegas G, Zhang X, Chua R, Melman A, Disanto ME. The sphingosine-1-phosphate pathway is upregulated in response to partial urethral obstruction in male rats and activates RhoA/Rho-kinase signalling. BJU Int 2010;106:562-71.
103. Cross BA. The posterior pituitary gland in relation to reproduction and lactation. Br Med Bull 1955;11:151-5.
104. Filippi S, Vignozzi L, Vannelli GB, Ledda F, Forti G, Maggi M. Role of oxytocin in the ejaculatory process. J Endocrinol Invest 2003;26:82-6.
105. Soloff MS, Swartz TL. Characterization of a proposed oxytocin receptor in the uterus of the rat and sow. J Biol Chem 1974;249:1376-81.
106. Argiolas A. Oxytocin stimulation of penile erection. Pharmacology, site, and mechanism of action. Ann N Y Acad Sci 1992;652:194-203.
107. Gimpl G, Fahrenholz F. The oxytocin receptor system: Structure, function, and regulation. Physiol Rev 2001;81:629-83.
108. Carmichael MS, Humbert R, Dixen J, Palmisano G, Greenleaf W, Davidson JM. Plasma oxytocin increases in the human sexual response. J Clin Endocrinol Metab 1987;64:27-31.
109. Murphy MR, Seckl JR, Burton S, Checkley SA, Lightman SL. Changes in oxytocin and vasopressin secretion during sexual activity in men. J Clin Endocrinol Metab 1987;65:738-41.
110. Ogawa S, Kudo S, Kitsunai Y, Fukuchi S. Increase in oxytocin secretion at ejaculation in male. Clin Endocrinol (Oxf) 1980;13:95-7.
111. Uckert S, Becker AJ, Ness BO, Stief CG, Scheller F, Knapp WH, Jonas U. Oxytocin plasma levels in the systemic and cavernous blood of healthy males during different penile conditions. World J Urol 2003;20:323-6.
112. Vignozzi L, Filippi S, Luconi M, Morelli A, Mancina R, Marini M, Vannelli GB, Granchi S, Orlando C, Gelmini S, Ledda F, Forti G, Maggi M. Oxytocin receptor is expressed in the penis and mediates an estrogen-dependent smooth muscle contractility. Endocrinology 2004;145:1823-34.
113. Vignozzi L, Vannelli GB, Morelli A, Mancina R, Marini M, Ferruzzi P, Crescioli C, Luconi M, Donati S, Fisher AD, Baldi E, Filippi S, Forti G, Maggi M. Identification, characterization and biological activity of oxytocin receptor in the developing human penis. Mol Hum Reprod 2005;11:99-106.
114. Zhang XH, Filippi S, Vignozzi L, Morelli A, Mancina R, Luconi M, Donati S, Marini M, Vannelli GB, Forti G, Maggi M. Identification, localization and functional in vitro and in vivo activity of oxytocin receptor in the rat penis. J Endocrinol 2005;184:567-76.
115. Filippi S, Luconi M, Granchi S, Vignozzi L, Bettuzzi S, Tozzi P, Ledda F, Forti G, Maggi M. Estrogens, but not androgens, regulate expression and functional activity of oxytocin receptor in rabbit epididymis. Endocrinology 2002;143:4271-80.
116. Shabsigh R, Rajfer J, Aversa A, Traish AM, Yassin A, Kalinchenko SY, Buvat J. The evolving role of testosterone in the treatment of erectile dysfunction. Int J Clin Pract 2006;60:1087-92.
117. Traish AM. Androgens play a pivotal role in maintaining penile tissue architecture and erection: A review. J Androl 2009;30:363-9.
118. Traish AM, Goldstein I, Kim NN. Testosterone and erectile function: From basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction. Eur Urol 2007;52:54-70.
119. Traish A, Kim N. The physiological role of androgens in penile erection: Regulation of corpus cavernosum structure and function. J Sex Med 2005;2:759-70.
120. Moreland RB, Traish A, McMillin MA, Smith B, Goldstein I, Saenz I. PGE1 suppresses the induction of collagen synthesis by transforming growth factor-beta 1 in human corpus cavernosum smooth muscle. J Urol 1995;153:826-34.
121. Raviv G, Kiss R, Vanegas JP, Petein M, Danguy A, Schulman C, Wespes E. Objective measurement of the different collagen types in the corpus cavernosum of potent and impotent men: An immunohistochemical staining with computerized-image analysis. World J Urol 1997;15:50-5.
122. Raviv G, Vanegas JP, Petein M, Schulman C, Danguy A, Kiss R, Wespes E. Biochemical alterations of the tunica albuginea in impotence. J Urol 1997;158:1778-82.
123. Luangkhot R, Rutchik S, Agarwal V, Puglia K, Bhargava G, Melman A. Collagen alterations in the corpus cavernosum of men with sexual dysfunction. J Urol 1992;148:467-71.
124. Persson C, Diederichs W, Lue TF, Yen TS, Fishman IJ, McLin PH, Tanagho EA. Correlation of altered penile ultrastructure with clinical arterial evaluation. J Urol 1989;142:1462-8.
125. Mersdorf A, Goldsmith PC, Diederichs W, Padula CA, Lue TF, Fishman IJ, Tanagho EA. Ultrastructural changes in impotent penile tissue: A comparison of 65 patients. J Urol 1991;145:749-58.
126. Wespes E, Goes PM, Schiffmann S, Depierreux M, Vanderhaeghen JJ, Schulman CC. Computerized analysis of smooth muscle fibers in potent and impotent patients. J Urol 1991;146:1015-7.
127. Jevtich MJ, Khawand NY, Vidic B. Clinical significance of ultrastructural findings in the corpora cavernosa of normal and impotent men. J Urol 1990;143:289-93.
128. Nehra A, Goldstein I, Pabby A, Nugent M, Huang YH, de las MA, Krane RJ, Udelson D, Saenz DT I, Moreland RB. Mechanisms of venous leakage: A prospective clinicopathological correlation of corporeal function and structure. J Urol 1996;156:1320-9.
129. Rogers RS, Graziottin TM, Lin CS, Kan YW, Lue TF. Intracavernosal vascular endothelial growth factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy prevent and reverse venogenic erectile dysfunction in rats. Int J Impot Res 2003;15:26-37.
130. Akishita M. [Hormone replacement Up-to-date. Effects of androgen replacement therapy on vascular function and atherosclerosis]. Clin Calcium 2007;17:1385-91.
131. Miller VM, Mulvagh SL. Sex steroids and endothelial function: Translating basic science to clinical practice. Trends Pharmacol Sci 2007;28:263-70.
132. Foresta C, Zuccarello D, De TL, Garolla A, Caretta N, Ferlin A. Androgens stimulate endothelial progenitor cells through an androgen receptor-mediated pathway. Clin Endocrinol (Oxf) 2008;68:284-9.
133. Lu YL, Kuang L, Zhu H, Wu H, Wang XF, Pang YP, Wang NJ, Yu DL. Changes in aortic endothelium ultrastructure in male rats following castration, replacement with testosterone and administration of 5alpha-reductase inhibitor. Asian J Androl 2007;9:843-7.
134. Giuliano F, Rampin O, Schirar A, Jardin A, Rousseau JP. Autonomic control of penile erection: Modulation by testosterone in the rat. J Neuroendocrinol 1993;5:677-83.
135. Yassin AA, Saad F, Traish A. Testosterone undecanoate restores erectile function in a subset of patients with venous leakage: A series of case reports. J Sex Med 2006;3:727-35.
136. Yassin AA, Saad F. Dramatic improvement of penile venous leakage upon testosterone administration. A case report and review of literature. Andrologia 2006;38:34-7.